Sustained immune complex-mediated reduction in CD16 expression after vaccination regulates NK cell function

Frontiers in Immunology

Volumn 7, Issue SEP, 2016, Pages

  Goodier, Martin R ^a   Lusa, Chiara ^a   Sherratt, Sam ^a   Rodriguez Galan, Ana ^a   Behrens, Ron ^a   Riley, Eleanor M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

CD16; CD25; CD57; Degranulation; Influenza; NK cells; Vaccination

Indexed keywords

CD16 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADULT; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; DEGRANULATION; DOWN REGULATION; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HOMEOSTASIS; HUMAN; HUMAN CELL; INFLUENZA VACCINATION; NATURAL KILLER CELL; NORMAL HUMAN; PROTEIN EXPRESSION; VACCINATION;

EID: 84992151505     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00384     Document Type: Article

References (35)

1. Horowitz A, Behrens RH, Okell L, Fooks AR, Riley EM. NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination. J Immunol (2010) 185(5):2808-18. doi: 10.4049/jimmunol.1000844
2. Jost S, Tomezsko PJ, Rands K, Toth I, Lichterfeld M, Gandhi RT, et al. CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination. J Virol (2014) 88(15):8349-54. doi:10.1128/JVI.00924-14
3. Goodier MR, Rodriguez-Galan A, Lusa C, Nielsen CM, Darboe A, Moldoveanu AL, et al. Influenza vaccination generates cytokine-induced memory-like NK cells: impact of human cytomegalovirus infection. J Immunol (2016) 197(1):313-25. doi:10.4049/jimmunol.1502049
4. Suliman S, Geldenhuys H, Johnson JL, Hughes JE, Smit E, Murphy M, et al. Bacillus Calmette-Guerin (BCG) revaccination of adults with latent Mycobacterium tuberculosis infection induces long-lived BCG-reactive NK cell responses. J Immunol (2016) 197(4):1100-10. doi:10.4049/jimmunol.1501996
5. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol (1999) 17:189-220. doi:10.1146/annurev.immunol.17.1.189
6. Cerwenka A, Lanier LL. Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol (2016) 16(2):112-23. doi:10.1038/nri.2015.9
7. Metes D, Galatiuc C, Moldovan I, Morel PA, Chambers WH, DeLeo AB, et al. Expression and function of Fc gamma RII on human natural killer cells. Nat Immun (1994) 13(6):289-300.
8. Stewart-Akers AM, Cunningham A, Wasko MC, Morel PA. Fc gamma R expression on NK cells influences disease severity in rheumatoid arthritis. Genes Immun (2004) 5(7):521-9. doi:10.1038/sj.gene.6364121
9. Wu Z, Sinzger C, Frascaroli G, Reichel J, Bayer C, Wang L, et al. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity. J Virol (2013) 87(13):7717-25. doi:10.1128/JVI.01096-13
10. Costa-Garcia M, Vera A, Moraru M, Vilches C, Lopez-Botet M, Muntasell A. Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus. J Immunol (2015) 194(6):2715-24. doi:10.4049/jimmunol.1402281
11. Zhang T, Scott JM, Hwang I, Kim S. Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRgamma deficiency. J Immunol (2013) 190(4):1402-6. doi:10.4049/jimmunol.1203034
12. Lee J, Zhang T, Hwang I, Kim A, Nitschke L, Kim M, et al. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity (2015) 42(3):431-42. doi:10.1016/j.immuni.2015.02.013
13. Dall'Ozzo S, Tartas S, Paintaud G, Cartron G, Colombat P, Bardos P, et al. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship. Cancer Res (2004) 64(13):4664-9. doi:10.1158/0008-5472.CAN-03-2862
14. Bowles JA, Wang SY, Link BK, Allan B, Beuerlein G, Campbell MA, et al. Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab. Blood (2006) 108(8):2648-54. doi:10.1182/blood-2006-04-020057
15. Konjevic G, Vuletic A, Mirjacic Martinovic K, Colovic N, Colovic M, Jurisic V. Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma. J Clin Pathol (2016) 15:203614. doi:10.1136/jclinpath-2016-203614
16. Liu Q, Sun Y, Rihn S, Nolting A, Tsoukas PN, Jost S, et al. Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection. J Virol (2009) 83(17):8705-12. doi:10.1128/JVI.02666-08
17. Tang CC, Isitman G, Bruneau J, Tremblay C, Bernard NF, Kent SJ, et al. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation. Clin Exp Immunol (2015) 181(2):275-85. doi:10.1111/cei.12593
18. Masuda M, Morimoto T, De Haas M, Nishimura N, Nakamoto K, Okuda K, et al. Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis. J Rheumatol (2003) 30(9):1911-17.
19. Peruzzi G, Femnou L, Gil-Krzewska A, Borrego F, Weck J, Krzewski K, et al. Membrane-type 6 matrix metalloproteinase regulates the activation-induced downmodulation of CD16 in human primary NK cells. J Immunol (2013) 191(4):1883-94. doi:10.4049/jimmunol.1300313
20. Romee R, Foley B, Lenvik T, Wang Y, Zhang B, Ankarlo D, et al. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood (2013) 121(18):3599-608. doi:10.1182/blood-2012-04-425397
21. Zhou Q, Gil-Krzewska A, Peruzzi G, Borrego F. Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy. Clin Exp Immunol (2013) 173(1):131-9. doi:10.1111/cei.12095
22. Goodier MR, White MJ, Darboe A, Nielsen CM, Goncalves A, Bottomley C, et al. Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions. Blood (2014) 124(14):2213-22. doi:10.1182/blood-2014-05-576124
23. Nielsen CM, White MJ, Bottomley C, Lusa C, Rodriguez-Galan A, Turner SE, et al. Impaired NK cell responses to pertussis and H1N1 influenza vaccine antigens in human cytomegalovirus-infected individuals. J Immunol (2015) 194(10):4657-67. doi:10.4049/jimmunol.1403080
24. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods (2004) 294(1-2):15-22. doi:10.1016/j.jim.2004.08.008
25. Mullberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-John S, Cosman D, et al. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol (1995) 155(11):5198-205.
26. Romee R, Schneider SE, Leong JW, Chase JM, Keppel CR, Sullivan RP, et al. Cytokine activation induces human memory-like NK cells. Blood (2012) 120(24):4751-60. doi:10.1182/blood-2012-04-419283
27. White MJ, Nielsen CM, McGregor RH, Riley EH, Goodier MR. Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens. Immunology (2014) 142(1):140-50. doi:10.1111/imm.12239
28. Popko K, Gorska E. The role of natural killer cells in pathogenesis of autoimmune diseases. Cent Eur J Immunol (2015) 40(4):470-6. doi:10.5114/ceji.2015.56971
29. Marco M, Fortin C, Fulop T. Membrane-type matrix metalloproteinases: key mediators of leukocyte function. J Leukoc Biol (2013) 94(2):237-46. doi:10.1189/jlb.0612267
30. Crowe PD, Walter BN, Mohler KM, Otten-Evans C, Black RA, Ware CF. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med (1995) 181(3):1205-10. doi:10.1084/jem.181.3.1205
31. DasGupta S, Murumkar PR, Giridhar R, Yadav MR. Studies on novel 2-imidazolidinones and tetrahydropyrimidin-2(1H)-ones as potential TACE inhibitors: design, synthesis, molecular modeling, and preliminary biological evaluation. Bioorg Med Chem (2009) 17(10):3604-17. doi:10.1016/j.bmc.2009.04.003
32. Capuano C, Romanelli M, Pighi C, Cimino G, Rago A, Molfetta R, et al. Anti-CD20 therapy acts via FcgammaRIIIA to diminish responsiveness of human natural killer cells. Cancer Res (2015) 75(19):4097-108. doi:10.1158/0008-5472.CAN-15-0781
33. Lopez-Verges S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood (2010) 116(19):3865-74. doi:10.1182/blood-2010-04-282301
34. Jegaskanda S, Job ER, Kramski M, Laurie K, Isitman G, de Rose R, et al. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J Immunol (2013) 190(4):1837-48. doi:10.4049/jimmunol.1201574
35. Jegaskanda S, Weinfurter JT, Friedrich TC, Kent SJ. Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques. J Virol (2013) 87(10):5512-22. doi:10.1128/JVI.03030-12